A new biotech startup tries to tackle obesity, but not in the way you might expect - STAT

A new biotech startup tries to tackle obesity, but not in the way you might expect - STAT
Health

Listen to this article

0%

A new startup is making a bold move in the world of obesity drug development: Its not working with the GLP-1 target that has taken the world by storm. Just a few years ago, the term GLP-1 would have… [+854 chars]

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Stay Connected